Melanoma Plasma

In Stock Samples

Lot # Condition Volume Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
79161 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79162 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79163 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79164 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79165 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79166 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79167 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79168 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00
79196 Melanoma 1.0 ML 57 Female
Amlodipine
1 $495.00
79169 Melanoma 1.0 ML 71 Male
Clopidogrel
1 $495.00

Melanoma Plasma | High-Quality Human Plasma from Melanoma Donors

Melanoma Plasma is collected from donors clinically diagnosed with melanoma and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on immune profiling, and biomarker discovery in melanoma pathophysiology.

Product Features

  • Research Use Only (RUO)
  • Plasma collected from clinically confirmed melanoma donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

De-identified Donor Data

  • Verified melanoma diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional melanoma-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Melanoma plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Frequently Asked Questions

Showing 13–24 of 31 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Bulk plasma is available: https://sanguinebio.com/product/human-bulk-plasma/

YES – The “Specify I/E Criteria” service allows you to define specific inclusion/exclusion criteria including lifestyle restrictions.

YES – Sanguine offers longitudinal collections.

YES – Sanguine offers matched samples across multiple matrices and age-matched controls.

1 2 3
×

Ask a Question

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information